The stock was last seen trading 5.18 per cent up at Rs 8,415.85. At this price, it has climbed 13.55 per cent in the past one ...

Jyoti Structures hit an upper circuit 10% at Rs 25.72 after the company's consolidated net profit soared to Rs 11.48 crore in Q3 FY25 as compared with Rs 1.08 crore in Q3 FY24.

Alembic Pharmaceuticals reported a 23.29% decline in Q3 FY25 net profit at ₹138.42 crore, despite a 3.81% revenue increase to ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

MercadoLibre has robust growth with significant ad revenue gains. See why MELI stock's high P/E ratio is justified, and why ...

Divi's Labs also said in its exchange filing that it has commenced commercial operations from a part of the Phase 1 of the ...

The company's revenue from operations jumped 25 percent year-on-year to Rs 2,319 crore during the quarter under review.

Divi's Laboratories Q3 Results: Divi's Laboratories on Monday reported an 64.5% year-on-year rise in its consolidated net profit (attributable to Shareholders of the Company) for the fiscal's third ...